Browsing by Author "Mella, J."
Now showing 1 - 9 of 9
Results Per Page
Sort Options
- ItemA combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus(2015) Andrades, J.; Campanini, J.; Vasquez, D.; Silvestri, C.; Morales, C.; Romero, J.; Mella, J.
- ItemA combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus(2015) Andrades, J.; Campanini, J.; Vasquez, D.; Silvestri, C.; Morales, C.; Romero Parra, Javier Hernán; Mella, J.
- ItemDevelopment of 3D-QSAR and pharmacophoric models to design new anti-Trypanosoma cruzi agents based on 2-aryloxynaphthoquinone scaffold(2022) Paulino, M.; Espinosa-Bustos, C.; Bertrand, J.; Cabezas, D.; Mella, J.; Davila, B.; Cerecetto, H.; Ballesteros-Casallas, A.; Salas, C. O.In this work we have collected a set of 30 trypanosomicidal naphthoquinones and developed pharmacophoric and 3D-QSAR models as tools for the design of new potential anti-Chagasic compounds. Firstly, qualitative information was obtained from SAR and pharmacophoric models identifying some fragments around the 2-aryloxynaphthoquinone scaffold important for the antiparasitic activity. Then, 3D-QSAR CoMFA and CoMSIA models were developed. The models showed adequate statistical parameters where the steric, electrostatic, and hydrophobic features explain the trypanosomicidal effect. Therefore, to validate our models, we carried out the design, synthesis, and biological evaluation on T. cruzi epimastigotes of five new compounds (33a-e). According to CoMFA model, three out of five compounds showed pIC(50) values within one logarithmic unit of deviation. The two compounds that did not fit the predictions were those with high lipophilicity, which agreed with the SAR and pharmacophore models. Docking and molecular dynamic studies were performed on T. cruzi trypanothione reductase, in a proposed binding site for this type of naphthoquinone. Interestingly, 33a-e showed the same interaction pattern as a naphthoquinone inhibitor (2). Finally, predicted drug-likeness properties indicated that 33a-e have optimal oral bioavailability. Thus, this study provides new in silico models for obtaining novel trypanosomicidal compounds.
- ItemExtended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation(2016) Vera, G.; Lagos, C.; Almendras Riesco, Sebastián Ignacio; Hebel, D.; Flores, F.; Valle, G.; Pessoa Mahana, Carlos David; Mella, J.; Montecinos Escobar, Rodrigo Andrés; Recabarren Gajardo, Gonzalo
- ItemImpact of Awake Prone Positioning on Inspiratory Effort and Work of Breathing. A Physiological Study in Healthy Subjects(American Thoracic Society, 2022) Damiani Rebolledo, L. Felipe; Basoalto Escobar, Roque Ignacio; Bachmann Barrón, María Consuelo; Jalil Contreras, Yorschua Frederick; Acuña, V.; Díaz, G.; Mella, J.; García Valdés, Patricio Hernán; Moya Gallardo, Eduardo Sebastián; Villarroel, G.; Retamal Montes, Jaime; Bugedo Tarraza, Guillermo; Bruhn, Alejandro
- ItemPromising 2,6,9-trisubstituted purine derivatives for anticancer compounds: Synthesis, 3D-QSAR, and preliminary biological assays(2020) Salas, C.O.; Zarate, A.M.; Kryštof, V.; Mella, J.; Faundez, M.; Brea, J.; Loza, M.I.; Brito, I.; Hendrychová, D.; Jorda, R.; Cabrera Caballero, Alan Raul; Tapia, R.A.; Espinosa-Bustos, C.
- ItemState of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures(2019) Espinosa-Bustos, C.; Mella, J.; Soto-Delgado, J.; Salas Sanchez, Cristian Osvaldo
- ItemStructure-activity relationships based on 3D-QSAR CoMFA/CoMSIA and design of aryloxypropanol-amine agonists with selectivity for the human β3-adrenergic receptor and anti-obesity and anti-diabetic profiles(2018) Lorca, M.; Morales-Verdejo, C.; Vasquez-Velasquez, David; Andrades-Lagos, J.; Campanini-Salinas, J.; Soto-Delgado, J.; Recabarren Gajardo, Gonzalo; Mella, J.